BNP PARIBAS FINANCIAL MARKETS - MINERVA NEUROSCIENCES INC ownership

MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 71 filers reported holding MINERVA NEUROSCIENCES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of MINERVA NEUROSCIENCES INC
ValueSharesWeighting
Q1 2022$442,000
+3.5%
5330.0%0.00%
Q4 2021$427,000
-57.6%
533
-7.9%
0.00%
Q3 2021$1,007,000
-25.0%
5790.0%0.00%
Q2 2021$1,343,000
-90.0%
579
-87.4%
0.00%
Q1 2021$13,423,000
-21.6%
4,597
-37.2%
0.00%
Q4 2020$17,117,000
-33.9%
7,315
-10.2%
0.00%
Q3 2020$25,911,000
+187.9%
8,148
+226.8%
0.00%
Q2 2020$9,000,000
-84.6%
2,493
-74.4%
0.00%
Q1 2020$58,605,000
+83.5%
9,735
+116.8%
0.00%
Q4 2019$31,931,000
-14.4%
4,491
-6.7%
0.00%
Q3 2019$37,316,000
+92.0%
4,815
+39.4%
0.00%
Q2 2019$19,440,000
-61.4%
3,453
-46.1%
0.00%
Q1 2019$50,335,000
+75026.9%
6,404
+63940.0%
0.00%
Q4 2018$67,000
-99.5%
10
-99.1%
0.00%
Q3 2018$14,081,000
+52.1%
1,1220.0%0.00%
Q2 2018$9,256,000
-72.2%
1,122
-78.9%
0.00%
Q1 2018$33,294,000
+1.9%
5,327
-1.3%
0.00%
Q4 2017$32,658,000
-4.6%
5,398
+19.8%
0.00%
Q3 2017$34,238,000
+67.1%
4,505
+94.6%
0.00%
Q2 2017$20,488,000
+2985.5%
2,315
+2723.2%
0.00%
Q1 2017$664,000
-94.7%
82
-92.3%
0.00%
Q4 2016$12,502,000
-32.8%
1,064
-19.3%
0.00%
Q3 2016$18,610,000
+188.4%
1,318
+108.5%
0.00%
Q2 2016$6,453,0006320.00%
Other shareholders
MINERVA NEUROSCIENCES INC shareholders Q3 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,652,436$31,166,0004.20%
NEXTHERA CAPITAL LP 492,958$5,792,0003.40%
Iguana Healthcare Management, LLC 150,000$1,763,0001.05%
Perceptive Advisors 810,537$9,523,0000.68%
HIGHLAND CAPITAL MANAGEMENT LP 1,141,333$13,411,0000.63%
FEDERATED HERMES, INC. 6,358,642$74,714,0000.22%
EAM Investors, LLC 137,685$1,618,0000.22%
Orbimed Advisors 556,200$6,535,0000.08%
J. Goldman & Co LP 103,281$1,214,0000.08%
Virtus ETF Advisers LLC 18,814$221,0000.07%
View complete list of MINERVA NEUROSCIENCES INC shareholders